Globalnews Digital / globalnews - Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.
Back to Top / Monday, November 3, 2025, 7:21 am / permalink 15610 / 4 stories in 4 months
Wellington-Altus sells 25% stake in multi-billion-dollar deal / 4 months
Cameco and Brookfield seal US nuclear reactor deal / 4 months
Cenovus delays MEG takeover vote amid shareholder doubts / 4 months
Undefined 'National Interest' Criteria Stump Critics in Major Projects Law / 4 months
Middle East conflict drives Canadian fuel prices and export debate / 2 days
Government suspends plastics export ban amid supply chain woes / 2 months
Bank of Canada eyes rate cuts amid trade turbulence / 4 months
NorthFeed Inc.
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.